Literature DB >> 32927242

Emotional and cognitive empathy in patients with non-epileptic seizures.

F Irorutola1, C Gerhardt2, K Hamouda2, M Rose2, K Hinkelmann2, P Senf-Beckenbach2.   

Abstract

OBJECTIVE: Evidence suggests that impairments in social cognition are associated with the occurrence of NES. Our aim was to investigate impairments in social cognition in the form of emotional and cognitive empathy in patients with NES compared to healthy controls.
METHODS: For this purpose, we recruited 41 patients with video-EEG secured NES and compared them to 41 healthy controls matched by age, gender and educational level. Emotional and cognitive empathy were assessed using the Multifaceted Empathy Task (MET) and the Read the Mind in the Eye Test (RMET). Self-assessment questionnaires were used to record psychopathology in both groups.
RESULTS: Patients with NES showed no differences in cognitive empathy compared to the healthy controls. Additionall, they seem to have less emotional empathy specifically towards positive emotions, compared to healthy controls. DISCUSSION: Our results are an indication of possible emotional empathy abnormalities in patients with NES. Those deviations, if replicated in large sample sizes, could implicate, that interventions for patients with NES should focus on improving empathy skills.
Copyright © 2020 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dissociation; Empathy; Non-Epileptic seizures; Psychogenic; Psychopathology; Theory of mind

Mesh:

Year:  2020        PMID: 32927242     DOI: 10.1016/j.seizure.2020.08.009

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  1 in total

1.  Evaluation of a new body-focused group therapy versus a guided self-help group program for adults with psychogenic non-epileptic seizures (PNES): a pilot randomized controlled feasibility study.

Authors:  Philine Senf-Beckenbach; Matthias Hoheisel; Janine Devine; Arnina Frank; Laura Obermann; Matthias Rose; Kim Hinkelmann
Journal:  J Neurol       Date:  2021-06-18       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.